Claritev Corp

CTEV

Market cap $773M

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation Announces Participation at Upcoming Conferences.

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced the pricing of an underwritten public offering (the “Offering”) of 1,500,000 shares of its Class A common stock, par value $0.0001 per share (the “Class A common stock”), by certain affiliates of Hellman & Friedman (collectively, the “Selling Stockholders”) at a price.

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced the commencement of an underwritten public offering (the “Offering”) of 1,500,000 shares of its Class A common stock, par value $0.0001 per share (the “Class A common stock”), by certain affiliates of Hellman & Friedman (collectively, the “Selling Stockholders”). The.

Claritev Corporation ( CTEV ) Q3 2025 Earnings Call November 7, 2025 8:00 AM EST Company Participants Todd Friedman - Vice President of Investor Relations Travis Dalton - CEO, President & Chairman Doug Garis - Executive VP & CFO Conference Call Participants Joshua Raskin - Nephron Research LLC Daniel Grosslight - Citigroup Inc. Exchange Research Jessica Tassan - Piper Sandler & Co., Research Division Presentation Operator Hello, everyone, and thank you for joining us today for the Claritev Corporation Third Quarter Earnings Call. My name is Sami, and I'll be coordinating your call today.

Claritev Corporation (CTEV) came out with a quarterly loss of $4.07 per share versus the Zacks Consensus Estimate of a loss of $3.12. This compares to a loss of $1.85 per share a year ago.

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation Reports Third Quarter 2025 Results.

MCCLEAN, Va. & RIYADH, Saudi Arabia--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a global leader in healthcare analytics and claims analysis, today announced a strategic investment in Klaim, Inc., an AI-driven healthcare payment-acceleration solutions provider. The investment will help fund the launch of a co-branded Payment Acceleration Service integrated within Claritev's extensive provider network, helping healthcare organizations gain faster and more pr.

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation Announces Third Quarter 2025 Earnings Call.

MCLEAN, Va. & DUBAI, United Arab Emirates--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, and iO Health-FZE, an innovator in AI-driven healthcare technology, today announced a strategic agreement aimed at delivering Optima AI across the Middle East and North Africa (MENA). Through this agreement, Claritev has secured exclusive rights to license,.

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced it has renewed its sponsorship agreement with professional golfer Neal Shipley and signed new sponsorship agreements with Bud Cauley, Ryan Fox and Darren Clarke. These endorsements reflect Claritev's commitment to supporting athletes who exemplify resilience, determinatio.